Connection
Ernesto Sparrelid to Hypoglycemic Agents
This is a "connection" page, showing publications Ernesto Sparrelid has written about Hypoglycemic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.121 |
|
|
|
-
Huang Y, Santoni G, Sparrelid E, Xie SH. Metformin use and the risk of liver cancer in a Swedish population-based cohort study. JNCI Cancer Spectr. 2026 May 09; 10(3).
Score: 0.121